Literature DB >> 16525030

Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14.

J V Warner, D R Nyholt, F Busfield, M Epstein, J Burgess, S Stranks, P Hill, D Perry-Keene, D Learoyd, B Robinson, B T Teh, J B Prins, J W Cardinal.   

Abstract

BACKGROUND: Familial isolated hyperparathyroidism (FIHP) is an autosomal dominantly inherited form of primary hyperparathyroidism. Although comprising only about 1% of cases of primary hyperparathyroidism, identification and functional analysis of a causative gene for FIHP is likely to advance our understanding of parathyroid physiology and pathophysiology.
METHODS: A genome-wide screen of DNA from seven pedigrees with FIHP was undertaken in order to identify a region of genetic linkage with the disorder.
RESULTS: Multipoint linkage analysis identified a region of suggestive linkage (LOD score 2.68) on chromosome 2. Fine mapping with the addition of three other families revealed significant linkage adjacent to D2S2368 (maximum multipoint LOD score 3.43). Recombination events defined a 1.7 Mb region of linkage between D2S2368 and D2S358 in nine pedigrees. Sequencing of the two most likely candidate genes in this region, however, did not identify a gene for FIHP.
CONCLUSIONS: We conclude that a causative gene for FIHP lies within this interval on chromosome 2. This is a major step towards eventual precise identification of a gene for FIHP, likely to be a key component in the genetic regulation of calcium homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525030      PMCID: PMC2563254          DOI: 10.1136/jmg.2005.035766

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Statistical tests for detection of misspecified relationships by use of genome-screen data.

Authors:  M S McPeek; L Sun
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 2.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor.

Authors:  Daniel Chi-Hong Lin; Clayton M Bullock; Frederick J Ehlert; Jin-Long Chen; Hui Tian; Qun-Yong Zhou
Journal:  J Biol Chem       Date:  2002-03-08       Impact factor: 5.157

4.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Authors:  J D Carpten; C M Robbins; A Villablanca; L Forsberg; S Presciuttini; J Bailey-Wilson; W F Simonds; E M Gillanders; A M Kennedy; J D Chen; S K Agarwal; R Sood; M P Jones; T Y Moses; C Haven; D Petillo; P D Leotlela; B Harding; D Cameron; A A Pannett; A Höög; H Heath; L A James-Newton; B Robinson; R J Zarbo; B M Cavaco; W Wassif; N D Perrier; I B Rosen; U Kristoffersson; P D Turnpenny; L-O Farnebo; G M Besser; C E Jackson; H Morreau; J M Trent; R V Thakker; S J Marx; B T Teh; C Larsson; M R Hobbs
Journal:  Nat Genet       Date:  2002-11-18       Impact factor: 38.330

5.  Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas.

Authors:  Jennifer E Rosen; Nick G Costouros; Dominique Lorang; A Lee Burns; H Richard Alexander; Monica C Skarulis; Craig Cochran; James F Pingpank; Stephen J Marx; Allen M Spiegel; Steven K Libutti
Journal:  Ann Surg Oncol       Date:  2005-03-31       Impact factor: 5.344

6.  Molecular classification of parathyroid neoplasia by gene expression profiling.

Authors:  Carl Morrison; William Farrar; Jeff Kneile; Nita Williams; Yiwen Liu-Stratton; Alan Bakaletz; Micheala A Aldred; Charis Eng
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.

Authors:  William F Simonds; Christiane M Robbins; Sunita K Agarwal; Geoffrey N Hendy; John D Carpten; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

8.  Involvement of protein kinase C-alpha and -epsilon in extracellular Ca(2+) signalling mediated by the calcium sensing receptor.

Authors:  Amos M Sakwe; Mårten Larsson; Lars Rask
Journal:  Exp Cell Res       Date:  2004-07-15       Impact factor: 3.905

9.  Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP).

Authors:  A Villablanca; A Calender; L Forsberg; A Höög; J-D Cheng; D Petillo; C Bauters; K Kahnoski; T Ebeling; P Salmela; A-L Richardson; L Delbridge; A Meyrier; C Proye; J D Carpten; B T Teh; B G Robinson; C Larsson
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

10.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

Authors:  J Warner; M Epstein; A Sweet; D Singh; J Burgess; S Stranks; P Hill; D Perry-Keene; D Learoyd; B Robinson; P Birdsey; E Mackenzie; B T Teh; J B Prins; J Cardinal
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

View more
  11 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 2.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature.

Authors:  Nikolaos Pontikides; Spyridon Karras; Athina Kaprara; Panagiotis Anagnostis; Gesthimani Mintziori; Dimitrios G Goulis; Eleni Memi; Gerasimos Krassas
Journal:  J Bone Miner Metab       Date:  2014-01-19       Impact factor: 2.626

4.  GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.

Authors:  Bin Guan; James M Welch; Julie C Sapp; Hua Ling; Yulong Li; Jennifer J Johnston; Electron Kebebew; Leslie G Biesecker; William F Simonds; Stephen J Marx; Sunita K Agarwal
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

Review 5.  Genetics of Hyperparathyroidism, Including Parathyroid Cancer.

Authors:  William F Simonds
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

Review 6.  Clinical and molecular genetics of parathyroid neoplasms.

Authors:  John M Sharretts; William F Simonds
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 7.  Hyperparathyroid genes: sequences reveal answers and questions.

Authors:  Stephen J Marx
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

8.  Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.

Authors:  O Vierimaa; A Villablanca; A Alimov; M Georgitsi; A Raitila; P Vahteristo; C Larsson; A Ruokonen; E Eloranta; T M L Ebeling; J Ignatius; L A Aaltonen; J Leisti; P I Salmela
Journal:  J Endocrinol Invest       Date:  2009-03-26       Impact factor: 4.256

9.  A Novel Germline c.1267T>A MEN1 Mutation in MEN1 Family-from Phenotype to Gene and Back.

Authors:  Wojciech Gierlikowski; Agata Skwarek-Szewczyk; Michał Popow
Journal:  Genes (Basel)       Date:  2020-11-21       Impact factor: 4.096

Review 10.  Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.

Authors:  Luís Cardoso; Mark Stevenson; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2017-09-25       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.